Enrichment of Sca1+ cells in Epo-treated mice
| Marker . | Treatment/mouse . | ||
|---|---|---|---|
| PBS/control . | PBS/F-MuLV . | Epo/F-MuLV . | |
| cKit | 0.9 ± 0.3 | 49.9 ± 2.1 | 15.2 ± 4.0* |
| Sca1 | 8.0 ± 1.7 | 4.0 ± 0.8 | 18.2 ± 3.8† |
| Ter119 | 4.7 ± 1.1 | 13.95 ± 5.5 | 32.6 ± 4.7† |
| CD19/B220 | 30.0 ± 3.2 | 7.9 ± 3.1 | 9.4 ± 1.7 |
| CD4 | 19.8 ± 0.7 | 2.05 ± 0.15 | 10.1 ± 1.25* |
| CD8 | 11.2 ± 4.0 | 1.8 ± 0.6 | 3.7 ± 0.2† |
| Gr1 | 16.2 ± 9.0 | 5.0 ± 1.45 | 9.6 ± 0.5† |
| Mac1 | 4.4 ± 0.65 | 0.9 ± 0.3 | 5.4 ± 0.9* |
| 33D1 | 36.7 ± 6.5 | 5.8 ± 0.2 | 10.3 ± 1.4† |
| Marker . | Treatment/mouse . | ||
|---|---|---|---|
| PBS/control . | PBS/F-MuLV . | Epo/F-MuLV . | |
| cKit | 0.9 ± 0.3 | 49.9 ± 2.1 | 15.2 ± 4.0* |
| Sca1 | 8.0 ± 1.7 | 4.0 ± 0.8 | 18.2 ± 3.8† |
| Ter119 | 4.7 ± 1.1 | 13.95 ± 5.5 | 32.6 ± 4.7† |
| CD19/B220 | 30.0 ± 3.2 | 7.9 ± 3.1 | 9.4 ± 1.7 |
| CD4 | 19.8 ± 0.7 | 2.05 ± 0.15 | 10.1 ± 1.25* |
| CD8 | 11.2 ± 4.0 | 1.8 ± 0.6 | 3.7 ± 0.2† |
| Gr1 | 16.2 ± 9.0 | 5.0 ± 1.45 | 9.6 ± 0.5† |
| Mac1 | 4.4 ± 0.65 | 0.9 ± 0.3 | 5.4 ± 0.9* |
| 33D1 | 36.7 ± 6.5 | 5.8 ± 0.2 | 10.3 ± 1.4† |
Flow cytometric analysis of spleen cells from uninfected control mice treated with PBS (n = 5) and F-MuLV–infected mice (60 days after infection) treated with either PBS or Epo (n = 6). Splenocytes were stained with cKit, Sca1, Ter119, B220, CD19, CD4, CD8, Gr-1, Mac-1, and 33D1. Values represent the mean ± SE.
P < .005.
P < .05.